HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Interviews

Set Alert for Interviews

From MoCRA Support To Battling Dangerous TikTok Trends: CEO Tom Myers On PCPC Priorities

The Personal Care Products Council is actively working with the FDA’s cosmetics office director Linda Katz and principal deputy commissioner Namandje Bumpus to ensure the agency has the tools it needs to continue rolling out MoCRA, says Tom Myers, the association's president and CEO. Also, the 2024 US presidential election and the problem of misinformation.

United States Regulation

PCPC’s Tom Myers On ‘Leaning Into’ State EPR Programs And Reflecting Members’ Corporate Ethos

In addition to sustainability, Myers noted DEI and advancing alternatives to animal testing among key priorities for the group. “We have member companies that really lead the way on many of those. We want to be able to amplify their good work and their messaging, because they are good corporate citizens” and “it’s what consumers are demanding anyway,” he said in an interview.

US States Regulation

‘It's Not Sustainable For Companies To Reformulate For One State’ – PCPC’s Karin Ross

Legislator education is key to checking state bills that overreach, says Ross, executive VP of government affairs at the Personal Care Products Council, discussing the rising tide of US state bills aimed at restricting ingredient use.

US States Legislation

Chevron Deference Muted, Higher Volume Ahead For US Supplement Market Regulatory Questions

Attorneys discuss potential impacts on consumer health products industry from Supreme Court’s “Loper Bright” decision in June on litigation brought by two fisheries, Loper Bright v. Raimondo and Relentless v. Department of Commerce.

FDA Litigation

Washington State Seeks Feedback As It Kicks Off Formaldehyde-Releasers Rulemaking

Numerous cosmetic ingredients that preserve cosmetics by releasing formaldehyde could be prohibited in products sold in Washington state in coming years, but stakeholders have a chance to weigh in now and shape the rulemaking. Shari Franjevic, implementation head for the Toxic-Free Cosmetics Act within the state's Department of Ecology, discusses.

Regulation US States

Proposal To Restrict Use Of Popular Supplement Ingredients In EU 'Highly Problematic'

FoodChain ID’s head of scientific affairs Jérôme Le Bloch discusses a proposal put to the European Commission by national food regulators to restrict on safety grounds the use of popular substances such as curcumin, melatonin and St John’s wort in supplements.

Dietary Supplements Europe

Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data

In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials. 

United States Beauty

Over The Counter: How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz

Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz.

Europe International

‘Is This Doomsday Concern, Or Is It Reality?’ Verily CMO On AI’s Future, Lightpath Metabolic, More

Andrew Trister, Verily’s chief medical and scientific officer, discusses Verily’s newly launched Lightpath Metabolic solution, featuring GLP-1 prescription, AI and strengthened clinical support. Plus, the Google health tech spinout's plans for the Study Watch, the Alzheimer’s research landscape, and AI development and regulation in a new era of uncertainty.

Digital Health Artificial Intelligence

AI Act: How To Preserve EU’s Industrial Competitiveness Through Proportionate Regulation

The AI medtech revolution could be a “huge, missed opportunity” for the EU without an effective and efficient regulatory infrastructure. Answers are needed fast, MedTech Europe’s Oliver Bisazza said during a recent interview.

Europe EU

Click Therapeutics Anticipates Pharma Will Begin Developing Digital Drugs From Clinical Stage

Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.

Digital Health Business Strategies

Over The Counter: Women’s Hormonal Wellness And The Power Of Herbs, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley

In this episode of HBW Insight's Over the Counter podcast, we chat with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness.

Europe Wellness

Digital Health Apps Have Underperformed, But VR Is ‘Very Different’ – Cedars-Sinai Virtual Medicine

Cedars-Sinai’s Virtual Medicine director Brennan Spiegel discusses the shortage of mental health professional resources and how Medical Extended Reality – e.g., immersing patients in a virtual world with an AI therapy avatar – is helping to address depression, pain, and a growing host of health and wellness needs in hospital and consumer settings.

Artificial Intelligence Behavioral Health

Over The Counter: How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone

In this episode of HBW Insight's Over the Counter podcast, we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer health companies need to know about this enormously complex and significant piece of EU legislation.

Europe Health

Get To Know: Fast-Growing, Stigma-Busting, ‘Omnichannel Thinking’ Karo Healthcare

Karo Healthcare has big plans for its expanding range of global OTC brands, the firm reveals in this exclusive Q&A. 

International Health

Plastic Packaging: The Search For Alternatives Must Be Pragmatic Not Emotionally Driven

Packaging manufacturer Logoplaste – supplier to major consumer health and cosmetics firms – speaks to HBW Insight about plastics and working with industry to develop alternatives.

International Health
See All
UsernamePublicRestriction

Register